Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Vitreoretinal surgery · New York | Vitreoretinal surgery · Pennsylvania | |
|---|---|---|
| Surgeons, 2024 | 42 | 45 |
| Medicare fee-for-service cases | 3,504 | 3,182 |
| Growth since 2019 (Medicare FFS) | −3.3%/yr | −0.1%/yr |
| Forecast cases (Medicare FFS) | 3,660 in 2030 | 3,020 in 2030 |
| Forecast growth | +0.7%/yr to 2030 | −0.9%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.9 | 2.4 |
| Medicare Advantage share | 57% | 58% |
| Out of hospital | 48% (+15 pts since 2019) | 49% (+4 pts since 2019) |
| Cases per surgeon | 83 | 71 |
| Top 10 surgeons' share | 43% | 50% |
| Surgeons growing | 6 | 7 |
| New since the base year | 5 | 6 |
| Likely to stop billing it | 7 by 2026 | 6 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $13K | $16K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.